Akebia Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AKBA Nasdaq 2836 www.akebia.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Akebia Therapeutics, Inc.

Akebia Therapeutics Sees Vafseo Uptake Rising as Access and Pipeline Milestones Near - Jun 4th, 2026 6:05 pm
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 1st, 2026 2:05 pm
Akebia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference - May 28th, 2026 6:00 am
Promising Penny Stocks To Consider In May 2026 - May 26th, 2026 6:05 am
Analysts Are Updating Their Akebia Therapeutics, Inc. (NASDAQ:AKBA) Estimates After Its First-Quarter Results - May 11th, 2026 6:27 am
Akebia (AKBA) Q1 2026 Earnings Transcript - May 8th, 2026 9:12 am
Akebia Therapeutics Q1 Earnings Call Highlights - May 7th, 2026 7:22 am
Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates - May 7th, 2026 6:50 am
Akebia Therapeutics Reports First Quarter 2026 Financial Results and Commercial and Pipeline Highlights - May 7th, 2026 5:00 am
United Therapeutics (UTHR) Misses Q1 Earnings and Revenue Estimates - May 6th, 2026 5:45 am
Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology - May 4th, 2026 6:00 am
Akebia Therapeutics to Report First Quarter 2026 Financial Results and Discuss Recent Business Highlights - Apr 30th, 2026 2:05 pm
Q32 Bio Gears Up to Report Q1 Earnings: What's in the Cards? - Apr 30th, 2026 1:10 pm
Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Tops Revenue Estimates - Apr 29th, 2026 6:25 am
Are Options Traders Betting on a Big Move in Akebia Therapeutics Stock? - Apr 28th, 2026 6:36 am
New Strong Sell Stocks for April 28th - Apr 28th, 2026 2:00 am
Germany Anemia Treatment Market Forecast and Company Analysis Report 2026-2034 Featuring Akebia Therapeutics, GSK, Vertex, Pfizer, Sanofi, Takeda, Novartis, Johnson & Johnson, Roche, Biocon Biologics - Apr 24th, 2026 7:04 am
Akebia Therapeutics Leads The Pack Of 3 Promising Penny Stocks - Apr 13th, 2026 6:05 am
Akebia Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of AKB-9090 - Apr 13th, 2026 6:00 am
Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium - Apr 7th, 2026 6:00 am